bm|t investment inflaRx from Jena goes public on the US stock exchange NASDAQ
Thuringia-based biotech company inflaRx (NASDAQ: IFRX) successfully completed its initial public offering on the US technology exchange Nasdaq yesterday, raising around $100 million. The company